Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$620K Sell
4,825
-68
-1% -$7.96K 0.23% 61
2026
Q1
$589K Sell
4,893
-243
-5% -$28.1K 0.24% 61
2025
Q4
$541K Sell
5,136
-170
-3% -$16K 0.22% 62
2025
Q3
$445K Sell
5,306
-166
-3% -$13.7K 0.19% 70
2025
Q2
$433K Sell
5,472
-846
-13% -$67.2K 0.21% 67
2025
Q1
$567K Sell
6,318
-1,290
-17% -$120K 0.3% 58
2024
Q4
$757K Sell
7,608
-1,757
-19% -$181K 0.43% 48
2024
Q3
$1.06M Sell
9,365
-1,763
-16% -$209K 0.61% 38
2024
Q2
$1.38M Buy
11,128
+497
+5% +$64K 0.85% 26
2024
Q1
$1.4M Buy
+10,631
New +$1.31M 0.94% 31

Other funds holding MRK

Emprise Bank's MRK Position: Q2 2026 in Review

Emprise Bank reduced its Merck (MRK) stake by 1.4% in Q2 2026, selling an estimated $7.96K and leaving 4,825 shares worth $620K. The position accounts for 0.23% of the portfolio, ranked #61.

Emprise Bank first reported a position in MRK in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.4M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Emprise Bank held 4,825 shares of Merck worth $620K as of Q2 2026.
  • Emprise Bank sold 68 Merck shares in Q2 2026, an estimated $7.96K.
  • Merck made up 0.23% of Emprise Bank's portfolio in Q2 2026, its #61 holding.
  • Emprise Bank first reported a position in Merck in Q1 2024 and has held it in 10 quarters since.
  • Emprise Bank's Merck position peaked at $1.4M in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Emprise Bank's 13F filing for Q2 2026, filed 7 Jul 2026.